
Global Platform for Access to Childhood Cancer Medicines
Undergoing chemotherapy treatment for a bladder tumour, 8-year-old Leonid had to leave a Kyiv hospital as the shelling escalated. He and his mother Anna set out in search of safety and treatment.
The Global Platform for Access to Childhood Cancer Medicines (Global Platform) aims to provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries (LMICs).
It is estimated that 400 000 children develop cancer every year. Close to 90% of them live in LMICs, where survival rates are less than 30%. This is in stark contrast to high-income countries, where survival rates exceed 80%. A significant cause of this disparity in survival is insufficient access to quality-assured, safe, effective and affordable medicines for childhood cancer. A number of initiatives for improving access to cancer medicines have been developed over the past decade.
The Global Platform will have the largest reach to children living with cancer of any programme to date, anticipating expansion to provide medicines to treat approximately 120 000 children in LMICs.
The Global Platform is made possible through the partnership between St Jude Children’s Research Hospital, the World Health Organization (WHO), UNICEF, and the Pan American Health Organization (PAHO) Strategic Fund.
Highlight

News
Multimedia
Fact sheet
Knowledge Action Portal (KAP)

The Global Platform Community of Practice
Welcome to the knowledge sharing community dedicated to enhancing multisectoral and multistakeholder collaboration of the Global Platform. Join us and discover the latest news, country stories and best practices on the implementation of the programme.
Initiative

WHO regional news
WHO coordinates Ghana’s enrolment on the Global Platform for Access to Childhood Cancer Medicines
Pakistan signs agreement with WHO to access free cancer medicines for 8000 children annually
El Salvador: Progress in Access to Childhood Cancer Medicines
Childhood Cancer Medicines Delivered to Cancer Diseases Hospital in Lusaka
WHO EMRO: International Childhood Cancer Day 2025
WHO, St. Jude, PAHO launch groundbreaking international delivery of childhood cancer medicines
Jordan joins the Global Platform for Access to Childhood Cancer Medicines
Uzbekistan joins the Global Platform for Access to Childhood Cancer Medicines
Nepal joins the Global Platform for Access to Childhood Cancer Medicines (GPACCM)
Health topic
